Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.

Inclusion Criteria: * 18 to 35 year old pregnant women (singleton) at \<=20 weeks of gestation (calculated from the LMP by study physician). * Willing to participate in the study and perform all measurements for self, husband and the offspring including anthropometry, dietary assessment, questionnaires and biological samples (blood and breast milk). * Willing to provide signed and dated informed consent. Exclusion Criteria: * Women allergic (if aware) to any of the test products. * Women at high risk for hemorrhagic bleeding, clotting (if aware). * Women with high-risk pregnancies (history and prevalence of pregnancy complications, including abruptio placentae, preeclampsia, pregnancy-induced hypertension, any serious bleeding episode in the current pregnancy, and/ or physician referral); and/or diagnosed chronic degenerative disease(s) such as diagnosed heart disease, cancer, stroke or diabetes (as omega-3 could raise blood sugar and lower insulin production). * Women consuming omega-3 supplements or having used these in 3 months preceding the intervention period. * Reported participation in another biomedical trial 3 months before the start of the study or during the study (not to get the results of the present study contaminated).